Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers

Dave Singh, Steven M. Fox, Ruth Tal-Singer, Jonathan Plumb, Stewart Bates, Peter Broad, John H. Riley, Bartolome Celli

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Induced sputum is used to sample inflammatory cells, predominantly neutrophils and macrophages, from the airways of COPD patients. The author's aim was to identify candidate genes associated with the degree of airflow obstruction and the extent of emphysema by expression profiling, and then to confirm these findings for selected candidates using PCR and protein analysis. Methods: Two sputum studies were performed in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 2-4 COPD ex-smokers from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort. First, gene array profiling at baseline in samples from 148 patients. The findings were replicated in a separate population of 176 patients using real-time PCR. The findings for one selected gene IL-18R were further analysed using immunohistochemistry in lung tissue and induced sputum from patients outside the ECLIPSE cohort. Results: Gene expression profiling revealed changes in 277 genes associated with GOLD stage 2 versus 3 and 4, and 198 genes with changes associated with the degree of emphysema (p
    Original languageEnglish
    Pages (from-to)489-495
    Number of pages6
    JournalThorax
    Volume66
    Issue number6
    DOIs
    Publication statusPublished - Jun 2011

    Fingerprint

    Dive into the research topics of 'Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers'. Together they form a unique fingerprint.

    Cite this